[Federal Register Volume 70, Number 157 (Tuesday, August 16, 2005)]
[Notices]
[Page 48167]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-16210]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recambinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.
    Name of Committee: Recombinant DNA Advisory Committee.
    Date: September 21, 2005.
    Time: 8 a.m. to 6 p.m.
    Agenda: The committee will review and discuss selected human gene 
transfer protocols as well as related data management activities.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.
    Contact Person: Laurie Lewallen, Advisory Committee Coordinator, 
Office of Biotechnology Activities, National Institutes of Health, 6705 
Rockledge Drive, Room 750, Bethesda, MD 20892-7985, (301) 496-9838, 
[email protected].
    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    Information is also available on the Institute's/Center's home 
page: http://www4.od.nih.gov/oba/, where an agenda and any additional 
information for the meeting will be posted when available.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
virtually every NIH and Federal research program in which DNA 
recombinant molecule techniques could be used, it has been determined 
not to be cost effective or in the public interest to attempt to list 
these programs. Such a list would likely require several additional 
pages. In addition, NIH could not be certain that every Federal program 
would be included as many Federal agencies, as well as private 
organizations, both national and international, have elected to follow 
the NIH Guidelines. In lieu of the individual program listing, NIH 
invites readers to direct questions to the information address above 
about whether individual programs listed in the Catalog of Federal 
Domestic assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: August 9, 2005.
Anthony M. Coehlo, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-16210 Filed 8-15-05; 8:45 am]
BILLING CODE 4140-01-M